financetom
Business
financetom
/
Business
/
Centessa Pharmaceuticals Insider Sold Shares Worth $719,940, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Centessa Pharmaceuticals Insider Sold Shares Worth $719,940, According to a Recent SEC Filing
Mar 27, 2026 1:39 AM

04:21 AM EDT, 03/27/2026 (MT Newswires) -- Gregory M Weinhoff, Chief Business Officer, on March 26, 2026, sold 23,998 shares in Centessa Pharmaceuticals ( CNTA ) for $719,940. Following the Form 4 filing with the SEC, Weinhoff has control over a total of 65,925 ordinary shares of the company, with 65,925 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1847903/000147083126000320/xslF345X05/wk-form4_1774571761.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Freshworks Shares Jump After Q3 Results Beat Estimates; Full-Year Outlook Raised
Freshworks Shares Jump After Q3 Results Beat Estimates; Full-Year Outlook Raised
Nov 9, 2024
12:30 PM EST, 11/07/2024 (MT Newswires) -- Freshworks ( FRSH ) shares jumped past 27% in recent Thursday trading, a day after posting its Q3 results ahead of analysts' estimates and raising its full-year outlook. The company reported Q3 non-GAAP diluted earnings late Wednesday of $0.11 per share, up from $0.08 a year earlier. Analysts polled by Capital IQ expected...
CoreCivic Shares Soar After Q3 Results Top Estimates, 2024 Outlook Raised
CoreCivic Shares Soar After Q3 Results Top Estimates, 2024 Outlook Raised
Nov 9, 2024
12:55 PM EST, 11/07/2024 (MT Newswires) -- CoreCivic ( CXW ) shares soared past 25% in recent Thursday trading, a day after the company posted quarterly results that exceeded analyst expectations and raised its earnings outlook for the year. The company reported Q3 adjusted earnings late Wednesday of $0.20 per diluted share, up from $0.14 a year earlier. Analysts polled...
ConocoPhillips Poised to Outperform Large-Cap E&P Peers, RBC Says
ConocoPhillips Poised to Outperform Large-Cap E&P Peers, RBC Says
Nov 9, 2024
12:31 PM EST, 11/07/2024 (MT Newswires) -- ConocoPhillips ( COP ) is in a position to outperform large-cap exploration and production peers with a strong balance sheet, competitive free cash flow generation, and scaled Permian assets, among others, RBC Capital Markets said in a note emailed Wednesday. The Q3 earnings call cleared investor concerns over 2025 outlook with solid financials...
--Kemper Keeps Quarterly Dividend at $0.31 a Share, Payable Dec. 4 to Shareholders of Record on Nov. 18
--Kemper Keeps Quarterly Dividend at $0.31 a Share, Payable Dec. 4 to Shareholders of Record on Nov. 18
Nov 9, 2024
12:57 PM EST, 11/07/2024 (MT Newswires) -- Price: 65.55, Change: -0.68, Percent Change: -1.03 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved